Solara Active Pharma Sciences Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025.
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences has submitted a routine compliance certificate to the stock exchanges (BSE and NSE) for the quarter ended June 30, 2025. The certificate was issued by Cameo Corporate Services Limited, the company's Registrar and Share Transfer Agent, on July 5, 2025. It confirms that all share certificates received for demat conversion during the quarter were properly verified, accepted or rejected, and that the original physical certificates were cancelled and the depository's name was recorded as the registered owner within the SEBI-prescribed timeline. The filing was signed by Pooja Jaya Kumar, Company Secretary, on July 17, 2025.
This is a standard, routine regulatory filing with no material impact on shareholders or the stock price. It simply confirms that the company's share dematerialisation and record-keeping processes are functioning smoothly as required by SEBI rules.